|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 31/4985 | |||
| A61K 31/513 | |||
| A61K 31/5517 | |||
| A61K 31/555 | |||
| A61K 31/704 | |||
| A61K 31/7068 | |||
| A61K 31/724 | |||
| A61K 33/24 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2173348 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08771559.5 |
| Europos patento paraiškos padavimo data | 2008-06-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-12-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/067614 |
| Data | 2008-06-20 |
| (87) | Numeris | WO 2009/006043 |
| Data | 2009-01-08 |
| (30) | Numeris | Data | Šalis |
| 947512 P | 2007-07-02 | US |
| (72) |
ABURUB, Aktham, US
CHEDID, Marcio, US
ENGLER, Thomas, Albert, US
VASUDEVAN, Venkatraghavan, US
|
| (73) |
Eli Lilly & Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | POTENTIATION OF CANCER CHEMOTHERAPY |
| POTENTIATION OF CANCER CHEMOTHERAPY |